136 related articles for article (PubMed ID: 22428065)
1. Effect of RECK gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features.
Chung TT; Yeh CB; Li YC; Su SC; Chien MH; Yang SF; Hsieh YH
PLoS One; 2012; 7(3):e33517. PubMed ID: 22428065
[TBL] [Abstract][Full Text] [Related]
2. Impact of RECK gene polymorphisms and environmental factors on oral cancer susceptibility and clinicopathologic characteristics in Taiwan.
Chung TT; Pan MS; Kuo CL; Wong RH; Lin CW; Chen MK; Yang SF
Carcinogenesis; 2011 Jul; 32(7):1063-8. PubMed ID: 21565829
[TBL] [Abstract][Full Text] [Related]
3. Reversion-Inducing-Cysteine-Rich Protein With Kazal Motifs (RECK) Gene Single Nucleotide Polymorphism With Hepatocellular Carcinoma: A Case-Control Study.
Bahgat DM; Shahin RM; Makar NN; Aziz AO; Hunter SS
J Clin Lab Anal; 2016 Jan; 30(1):36-40. PubMed ID: 25278269
[TBL] [Abstract][Full Text] [Related]
4. RECK Gene Promoter rs10814325 Polymorphism in Egyptian Patients with Hepatocellular Carcinoma on Top of Chronic Hepatitis C Viral Infection.
Fakhry AB; Ahmed AI; AbdelAlim MA; Ramadan DI
Asian Pac J Cancer Prev; 2016; 17(5):2383-8. PubMed ID: 27268601
[TBL] [Abstract][Full Text] [Related]
5. RECK gene polymorphisms influence NSCLC susceptibility, but not the chemotherapy response status in Chinese cohort.
Chen X; Jiang F; Shi N; Zhou H; Zhang L; Chen Y; Zheng Y; Yan TG
Cell Biochem Biophys; 2014 Jul; 69(3):567-71. PubMed ID: 24510537
[TBL] [Abstract][Full Text] [Related]
6. RECK Variants are Associated with Clinicopathological Features and Decreased Susceptibility in Mexican Patients with Colorectal Cancer.
María Márquez-González R; Margarita Saucedo-Sariñana A; Barros-Núñez P; Patricia Gallegos-Arreola M; Ibet Juárez-Vázquez C; Daniel Pineda-Razo T; Eugenia Marin-Contreras M; Esperanza Flores-Martínez S; Alejandra Rosales-Reynoso M
Tohoku J Exp Med; 2022 Jun; 257(2):163-169. PubMed ID: 35444107
[TBL] [Abstract][Full Text] [Related]
7. RECK Gene Polymorphism is Associated with Susceptibility and Prognosis of Wilms' Tumor in Chinese Children.
Yu Y; Hu Y; Li K; Chen Z; Zhang H; Zhang L
Med Sci Monit; 2015 Jul; 21():1928-33. PubMed ID: 26141647
[TBL] [Abstract][Full Text] [Related]
8. Effects of EZH2 polymorphisms on susceptibility to and pathological development of hepatocellular carcinoma.
Yu YL; Su KJ; Hsieh YH; Lee HL; Chen TY; Hsiao PC; Yang SF
PLoS One; 2013; 8(9):e74870. PubMed ID: 24040354
[TBL] [Abstract][Full Text] [Related]
9. RECK gene polymorphisms in hepatitis B-related hepatocellular carcinoma: A case-control study.
Said EM; Salem AA; Shousha HI; Ahmad ES; Alazzouny MA; Ahmed IA; Elfeky HM; Abdelsalam FM
Arab J Gastroenterol; 2022 Aug; 23(3):201-205. PubMed ID: 35941073
[TBL] [Abstract][Full Text] [Related]
10. RASSF1A, RECK genotypes and haplotypes in Egyptian population with Hepatocellular carcinoma.
Abd-Elfatah G; Gad-Allah AN
Immunol Lett; 2016 May; 173():36-41. PubMed ID: 26921475
[TBL] [Abstract][Full Text] [Related]
11. Association of intercellular adhesion molecule-1 single nucleotide polymorphisms with hepatocellular carcinoma susceptibility and clinicopathologic development.
Chen TP; Lee HL; Huang YH; Hsieh MJ; Chiang WL; Kuo WH; Chou MC; Yang SF; Yeh CB
Tumour Biol; 2016 Feb; 37(2):2067-74. PubMed ID: 26341495
[TBL] [Abstract][Full Text] [Related]
12. Correlation of Chitinase 3-Like 1 Single Nucleotide Polymorphisms with Hepatocellular Carcinoma in Taiwan.
Huang WS; Lin HY; Yeh CB; Chen LY; Chou YE; Yang SF; Liu YF
Int J Med Sci; 2017; 14(2):136-142. PubMed ID: 28260989
[TBL] [Abstract][Full Text] [Related]
13. CD44 gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features.
Chou YE; Hsieh MJ; Chiou HL; Lee HL; Yang SF; Chen TY
Biomed Res Int; 2014; 2014():231474. PubMed ID: 24971320
[TBL] [Abstract][Full Text] [Related]
14. Effects of E-cadherin (CDH1) gene promoter polymorphisms on the risk and clinicopathological development of hepatocellular carcinoma.
Chien MH; Yeh KT; Li YC; Hsieh YH; Lin CH; Weng MS; Kuo WH; Yang SF
J Surg Oncol; 2011 Sep; 104(3):299-304. PubMed ID: 21462191
[TBL] [Abstract][Full Text] [Related]
15. p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: a case-control study.
Sümbül AT; Akkız H; Bayram S; Bekar A; Akgöllü E; Sandıkçı M
Mol Biol Rep; 2012 Feb; 39(2):1639-47. PubMed ID: 21607615
[TBL] [Abstract][Full Text] [Related]
16. Methylation degree of metalloproteinase inhibitor RECK gene: Links to RECK protein level and hepatocellular carcinoma in chronic HCV infection patients.
Abo El-Khair SM; Elalfy H; Diasty M; Ebrahim EE; Elsamanoudy AZ
J Biochem Mol Toxicol; 2021 Oct; 35(10):e22886. PubMed ID: 34392581
[TBL] [Abstract][Full Text] [Related]
17. Relationship of interleukin-8 gene polymorphisms with hepatocellular carcinoma susceptibility and pathological development.
Chien MH; Yeh CB; Li YC; Wei LH; Chang JH; Peng YT; Yang SF; Kuo WH
J Surg Oncol; 2011 Dec; 104(7):798-803. PubMed ID: 21780129
[TBL] [Abstract][Full Text] [Related]
18. The silencing of RECK gene is associated with promoter hypermethylation and poor survival in hepatocellular carcinoma.
Zhang C; Ling Y; Zhang C; Xu Y; Gao L; Li R; Zhu J; Fan L; Wei L
Int J Biol Sci; 2012; 8(4):451-8. PubMed ID: 22419890
[TBL] [Abstract][Full Text] [Related]
19. MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population.
Akkiz H; Sümbül AT; Bayram S; Bekar A; Akgöllü E
Cancer Epidemiol; 2010 Aug; 34(4):448-52. PubMed ID: 20447891
[TBL] [Abstract][Full Text] [Related]
20. Recent Updates on the Therapeutic Prospects of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Liver Injuries.
Palladini G; Di Pasqua LG; Croce AC; Ferrigno A; Vairetti M
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
